TrialCPT: pharmacometrics & systems pharmacology2017

A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients.

E Schindler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.